Skip to content
Friday, August 07, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Holocaust Museum LA Names Honorary Director, Skirball Sunset Concerts Continues with Innovative Rockers August 7, 2026
  • Israeli court delays Ben-Gvir’s plans for an Israeli ‘Crocodile Alcatraz’ August 7, 2026
  • Israeli court delays Ben-Gvir’s plans for an Israeli ‘Crocodile Alcatraz’ August 7, 2026
  • Montenegro’s tiny Jewish community navigates uncertain territory as hostility toward Israel increases August 7, 2026
  • From fake burps to reverse tashlich, new children’s books bring the High Holidays to life August 7, 2026
  • Over 95% of Canadian Jewish university students report exposure to antisemitism August 6, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.